New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity–could anti-LIN28A enhance precision in diagnostics?
Annals of the Rheumatic Diseases · 2025
DOI: 10.1016/j.ard.2025.04.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025. Verfasst von Ioannis Parodis und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden; Center for Mole…. Hauptthemen laut MEDLINE: Autoantibodies, DNA-Binding Proteins, Immunoglobulin A, Immunoglobulin G. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Örebro Universitet, Centro Hospitalar Universitário do Porto, Innovative Medicines Initiative.
Abstract (Originalsprache)
OBJECTIVES: In response to the urgent unmet needs of heterogeneity, unpredictability, and diagnostic delay in systemic lupus erythematosus (SLE), we aimed to identify and validate new immunoglobulin (Ig)G and IgA autoantibody specificities. METHODS: Using a KoRectly EXpressed technology-based microarrays (i-Ome Discovery; Sengenics), we screened for circulating IgG and IgA autoantibodies against 1609 proteins in 2 independent cohorts (discovery: NTC02890121; validation: NCT02890134) comprising patients with SLE (n = 199 and n = 30), primary Sjögren's disease (n = 115 and n = 31), and systemic sclerosis (n = 115 and n = 24), and healthy controls (HCs; n = 111 and n = 84), respectively. RESULTS: We identified and validated 5 IgG (anti-Lin-28 homolog A [LIN28A], anti-HNRNPA2B1, anti-HMG20B, anti-HMGB2, and anti-alpha-globin transcription factor CP2 [TFCP2]) and 4 IgA (anti-LIN28A, anti-HMG20B, anti-SUB1, and anti-TFCP2) autoantibodies that demonstrated high specificity for SLE (0.91-0.94), along with consistent and robust positivity (0.22-0.69) in differentially abundant autoantibody (daAAb) analysis between SLE and comparator groups. IgG and IgA anti-LIN28A levels varied over a 14-month follow-up in the validation cohort of newly diagnosed patients with SLE and exhibited metrics that outperformed those of traditional autoantibody markers such as anti-double-stranded DNA. Clustering of patients with SLE based on autoantibody positivity (levels above the HC median plus 2 IQRs in the discovery cohort) status revealed 1 subgroup demonstrating seroreactivity against multiple antigens, 3 exhibiting varying reactivity, and 1 showing no reactivity. In pathway analysis, daAAb targets pointed to DNA-binding and RNA-binding and transcription functions. CONCLUSIONS: Novel autoantibodies validated in this study may enhance diagnostics and molecular characterisation in SLE. The prominent IgA seroreactivity implicates important roles of mucosal tissues in SLE autoimmunity, warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden; Center for Molecular Medicine, Stockholm, Sweden; Department of Rheumatology, Faculty…
- Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden; Center for Molecular Medicine, Stockholm, Sweden.
- Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
- Department of Clinical Sciences and Community Health, Università Degli Studi di Milano, Milan, Italy; IRCCS, Istituto Auxologico Italiano, Milan, Italy.
- Sengenics Corporation Pte Ltd, Singapore, Singapore.
- GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada/Andalusian Regional Government, Medical Genomics, Granada, Spain; Department of Genetics, Faculty of Sciences, University of Granada, Gr…
Förderung
- Örebro Universitet
- Centro Hospitalar Universitário do Porto
- Innovative Medicines Initiative
- Swedish Society of Medicine
- Medizinischen Hochschule Hannover
- Hospital Clínic de Barcelona
- Karolinska Institutet
- Foundation King Gustaf V 80-årsfond
Zitieren
APA
Parodis, I., Lagutkin, D., Lindblom, J., Idborg, H., Beretta, L., Borghi, M. O., PRECISESADS Clinical Consortium, Peyper, J. M., Barturen, G., Jakobsson, P. J., Alarcón-Riquelme, M. E., Sherina, N., & Nikolopoulos, D. (2025). New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity–could anti-LIN28A enhance precision in diagnostics?. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.04.003
Vancouver
Parodis I, Lagutkin D, Lindblom J, Idborg H, Beretta L, Borghi MO, et al. New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity–could anti-LIN28A enhance precision in diagnostics?. Annals of the Rheumatic Diseases. 2025. doi:10.1016/j.ard.2025.04.003
BibTeX
@article{Parodis2025,
author = {Parodis, Ioannis and Lagutkin, Denis and Lindblom, Julius and Idborg, Helena and Beretta, Lorenzo and Borghi, Maria Orietta and PRECISESADS Clinical Consortium, PRECISESADS Clinical Consortium and Peyper, Janique M and Barturen, Guillermo and Jakobsson, Per-Johan and Alarcón-Riquelme, Marta E and Sherina, Natalia and Nikolopoulos, Dionysis},
title = {New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity–could anti-LIN28A enhance precision in diagnostics?},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
doi = {10.1016/j.ard.2025.04.003}
}
EUVIMED